- Active Substance: Examorelin
- Concentration: 2 mg
- Pack Size: vial
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: Hexarelin
SKU: P258
Shipping From
Understanding Ultima-Hexarelin (Examorelin) 2mg for Growth Hormone
Ultima-Hexarelin, offered by Ultima Pharmaceuticals, contains 2mg per vial of Examorelin, also known as Hexarelin or HEX. This synthetic hexapeptide is a subject of active research in endocrinology due to its significant ability to stimulate the release of growth hormone (GH) from the pituitary gland.
Mechanism of Action
Examorelin acts as a potent growth hormone secretagogue by binding to the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Research indicates that Hexarelin can stimulate GH release even at low doses and may have a different receptor binding profile compared to other GH-releasing peptides, warranting further investigation into its specific mechanisms and downstream effects on the endocrine system.
Benefits
- Investigated for its strong stimulatory effect on growth hormone secretion in various research models.
- Studied for its potential to influence IGF-1 (Insulin-like Growth Factor 1) levels secondary to GH release.
- Research into its effects on body composition, including lean muscle mass and fat reduction (as a consequence of GH release).
- Exploration of its potential role in counteracting age-related decline in growth hormone levels.
- Studies on its unique receptor interactions and their implications for GH axis modulation.
Please note: The potential benefits listed above are based on preclinical and some limited clinical research and have not been fully established in humans for widespread therapeutic use. Examorelin is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions.
Usage Guidelines
As a research compound, any guidelines regarding its use are strictly within the context of laboratory and research settings. Administration protocols and dosages vary significantly depending on the specific research objectives and models. Common routes of administration in research include subcutaneous or intravenous injection. Dosing frequency and timing are often carefully controlled to study pulsatile GH release and its downstream effects. Any information regarding human dosage or administration is speculative and not recommended.
Potential Side Effects
Research on Examorelin has reported potential side effects such as a temporary increase in prolactin and cortisol levels, as well as possible mild and transient flushing. The long-term safety profile and the full range of potential side effects are still under investigation.
FAQ
What is Ultima-Hexarelin (Examorelin)?
Ultima-Hexarelin contains Examorelin, a peptide being researched for its potent ability to stimulate the release of growth hormone from the pituitary gland.
How does Examorelin work in research to stimulate growth hormone?
Research indicates it binds to the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in the pituitary gland, triggering GH release.
What are the potential research benefits of Examorelin?
Potential research benefits include strong growth hormone stimulation and subsequent effects on IGF-1 levels and body composition.
What are the potential side effects observed in research?
Research has reported potential temporary increases in prolactin and cortisol levels, as well as mild flushing.
Important Note: Ultima-Hexarelin is a research compound and is not approved for human therapeutic use by regulatory authorities in many regions. Information provided here is strictly for research and informational purposes only. It is not intended as a guide for personal use. The use of such compounds carries potential risks, and their long-term effects are not fully understood. Consult with qualified healthcare professionals for any health concerns.